• Mitomycin has been associated with microangiopathic hemolytic anemia and renal failure. We describe a patient with the adult hemolytic-uremic syndrome due to mitomycin who was successfully treated with intense plasma exchange therapy and corticosteroid therapy. Patients receiving mitomycin should have their conditions monitored closely for acute renal failure, thrombocytopenia, and hemolytic anemia.
(Arch Intern Med 1983;143:1617-1618)
Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonkar S, Jacobs MG. Mitomycin- Induced Hemolytic-Uremic Syndrome: Successful Treatment With Corticosteroids and Intense Plasma Exchange. Arch Intern Med. 1983;143(8):1617–1618. doi:10.1001/archinte.1983.00350080139033
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: